Across global markets, banks are embedding AI into core decision-making systems to strengthen predictive accuracy and remain competitive in digital finance. Modern banking operates in an environment ...

ISTANBUL, March 2 (Reuters) - The Turkish economy expanded 3.4% year-on-year in the fourth quarter, bringing full-year growth to 3.6%, official data showed on Monday, with both levels being just below ...

Eos Energy Enterprises (EOSE) -10.1% in Friday's trading, its second straight sharp decline that totals more than 40%, after reporting much lower than expected Q4 adjusted earnings and revenues while ...

Nvidia exceeded analysts' top- and bottom-line expectations for the fourth quarter of fiscal 2026. Management forecast strong year-over-year revenue growth in Q1 2027. Nvidia stock provides great AI ...

This repository contains the official source code and data for the research paper: "Enhancing stock price forecasting with a modular deep learning framework incorporating plug-and-play Transformer ...

Learn how to model 1D motion in Python using loops! 🐍⚙️ This step-by-step tutorial shows you how to simulate position, velocity, and acceleration over time with easy-to-follow Python code. Perfect ...

Across the recent three months, 15 analysts have shared their insights on Synchrony Financial (NYSE:SYF), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

Abstract: While Long Short-Term Memory (LSTM) networks are pivotal for time-series forecasting, their fixed recurrent structure struggles to capture the complex dynamics of financial markets, such as ...

Anthropic launched Claude Opus 4.6 on Thursday, triggering double-digit losses in financial technology stocks FactSet plunged 9.1%, S&P Global declined 4.2%, and Moody’s fell 3.3% after the AI model ...

Anthropic is releasing a new version of its most powerful AI model that’s designed to carry out financial research, days after the company’s push into legal services upended the stocks of legacy ...

After making a deal with the Trump administration to lower prices of GLP-1s, Wegovy and Ozempic maker Novo Nordisk expects a drop in revenue for 2026. The decline comes amid higher competition and ...